HHS announced a sweeping effort aimed at strengthening America's role in clinical research, accelerating the development of ...
WASHINGTON - The Department of Health and Human Services launched a department-wide initiative this week aimed at ...
The next evolution of Suvoda IRT is designed to accelerate study builds and change orders, elevate user experience, and deliver intelligent insights CONSHOHOCKEN, Pa., April 21, 2026 /PRNewswire/ -- ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...
HHS Secretary Robert F. Kennedy Jr. wants to speed up clinical trials in the United States.“A recent study found that China ...
Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.